EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Progress in the treatment of advanced gastric cancer

Zheyu Song, Yuanyu Wu, Jiebing Yang, Dingquan Yang, Xuedong Fang

Tumor Biology · 2017-07 · 39 (7) · 101042831771462

DOI: 10.1177/1010428317714626 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Tumor Biology, online erschienen am 03.07.2017. Verfasst von Zheyu Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of General Surgery, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China. Hauptthemen laut MEDLINE: Early Detection of Cancer. Die Arbeit wurde bisher 742-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer is one of the most common malignant tumors in the digestive system. Surgery is currently considered to be the only radical treatment. As surgical techniques improve and progress is made in traditional radiotherapy, chemotherapy, and the implementation of neoadjuvant therapy, the 5-year survival rate of early gastric cancer can reach >95%. However, the low rate of early diagnosis means that most patients have advanced-stage disease at diagnosis and so the best surgical window is missed. Therefore, the main treatment for advanced gastric cancer is the combination of neoadjuvant chemoradiotherapy, molecular-targeted therapy, and immunotherapy. In this article, we summarize several common methods used to treat advanced gastric cancer and discuss the progress made in the treatment of gastric cancer in detail. Only clinical practice and clinical research will allow us to prolong the survival time of patients and allow the patients to truly benefit by paying attention to the individual patient characteristics, drug choice, and developing a reasonable and comprehensive treatment plan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerCombined Modality TherapyDisease-Free SurvivalGastrectomyHumansMolecular Targeted TherapyNeoplasm StagingStomach Neoplasms

Stichwörter der Autor:innen

Advanced gastric cancerimmunotherapymolecular-targeted therapies radiotherapyneoadjuvant chemotherapy

Autor:innen und Institutionen

  • 1 Department of General Surgery, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
  • 2 Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, People's Republic of China.

Zitieren

APA

Song, Z., Wu, Y., Yang, J., Yang, D., & Fang, X. (2017). Progress in the treatment of advanced gastric cancer. Tumor Biology, 39(7), 101042831771462. https://doi.org/10.1177/1010428317714626

Vancouver

Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumor Biology. 2017;39(7):101042831771462. doi:10.1177/1010428317714626

BibTeX
@article{Song2017,
  author = {Song, Zheyu and Wu, Yuanyu and Yang, Jiebing and Yang, Dingquan and Fang, Xuedong},
  title = {Progress in the treatment of advanced gastric cancer},
  journal = {Tumor Biology},
  year = {2017},
  volume = {39},
  number = {7},
  pages = {101042831771462},
  doi = {10.1177/1010428317714626}
}
Kostenlos starten →